PARIS – Beiersdorf AG stock held steady Thursday hours after the German beauty giant downgraded its consumer business’ sales growth, due to the ongoing slowdown of the skin care market.
“We saw a further deceleration of the skin care market in the third quarter of 2025, especially in emerging markets, which is why we now expect an organic sales growth for our consumer business of around 2.5 percent for the full year,” said Beiersdorf chief executive officer Vincent Warnery, in a statement.
The group had previously forecasted approximately 3 percent sales gains for the year.
At 1:15 p.m. CET, Beiersdorf stock was trading at 96.34, up 0.2 percent.
The maker of Nivea, La Prairie and Chantecaille products’ sales in the third quarter, ended Sept. 30, were 2.35 billion euros, down 0.9 percent on a reported basis and up 1.7 percent in like-for-like terms.
In the first nine months of the year, Beiersdorf sales reached 7.54 billion euros, a 0.1 percent dip on a reported basis and 2 percent rise in like-for-like terms. Company gains were driven by Derma results.
La Prairie Skin Caviar Luxe Eye Cream
Courtesy
Beiersdorf has sought to refuel its cash-cow Nivea’s growth in today’s challenging market.
“The biggest Nivea launch of all time with our breakthrough ingredient Epicelline shows very promising early results,” Warnery said. “By broadening our skin care focus and reinforcing deodorants as a strategic growth pillar, we are strengthening Nivea’s position for longterm success. Our strategy for Nivea remains on track.”
Jefferies analyst David Hayes spotlighted a step-up in Nivea growth in September – at plus 8 percent on innovation rollout – but wrote in a note that it “only highlights the core brand is struggling (July/Aug. around minus 4.5 percent). The strategic reset demands investors reconsider what now? – that may take time.”